High Growth in the European Breast Reconstruction Market due to Successful Biologic Products; Led by LifeCell
Vancouver, BC (PRWEB) May 14, 2015 -- According to a recently published report by iData Research (http://www.idataresearch.com), the European breast reconstruction market has experienced some of the highest growth in recent years driven by a shift towards tissue expander/implant (TEI) based products. The success of biologics in this segment has had a tremendous effect on the market as a whole.
“Premium priced products represented a majority share of the total European breast reconstruction market which drove up the total market value considerably,” explains Dr. Kamran Zamanian, CEO of iData. “But the increasing proportion of TEI-based breast reconstructions, coupled with the ever increasing adoption rates of biologic matrices in this indication, contributed to substantial growth of the overall market in 2014.”
Compared to the U.S. market, allografts were not used substantially in Europe due to the strict regulations surrounding the use of human tissue for soft tissue regeneration. Therefore, the increasing adoption and subsequent growth in biologics is limited by diagnostics-related group based reductions in reimbursement throughout Europe.
Other key findings from the 2015 edition of the iData Research report entitled European Markets for Soft Tissue Reinforcement and Regeneration:
High Patient Satisfaction
Aesthetically pleasing results are crucial for breast reconstruction, as it results in positive postoperative psychological well-being of patients. The newer biologic and more advanced resorbable synthetic products offer exceptional aesthetic results by dramatically reducing the chances of scarring and allowing for better symmetry between breasts. As technologically advanced and safer products become more popular, the percentage of patients opting for breast reconstruction following mastectomy will continue to rise.
Leading Competitors
In 2014, LifeCell was the leading competitor in the European breast reconstruction market with nearly 70% market share. This is mainly due to their dominance in the biologic segment of the breast reconstruction market with their Strattice™ reconstructive tissue matrix product, which is one of the most expensive products sold in Europe. LifeCell has therefore been able to command a price premium because of favorable clinical results.
Other notable competitors in the European soft tissue reinforcement and regeneration market include PFM Medical, Baxter / Synovis, Novus Scientific, C.R. Bard, Cook Medical, Cousin Biotech, Covidien, DECOmed, Epiflex, Ethicon, Mentor, Serag-Wiessner, TEI Biosciences, Tutogen, W.L. Gore, amongst many others. The full iData report includes market share analysis for more than 20 companies across 7 distinct market segments.
For Further Information
More on the breast reconstruction market in Europe can be found in the report series published by iData entitled Europe Soft Tissue Reinforcement and Regeneration Market. This report covers Europe markets for breast reconstruction, hernia repair, dural repair, vaginal slings, skin repair, sports medicine and tendon reinforcements, and dental soft tissue regeneration.
The iData series on the market for soft tissue reinforcement and regeneration covers the U.S. and 15 countries in Europe. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
Register online or email us at info(at)idataresearch(dot)net for a Europe Soft Tissue Reinforcement and Regeneration Market report brochure and synopsis.
About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by country, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.
Marvin Cidamon, iData Research, http://www.idataresearch.com/, +1 (604) 266-6933 Ext: 205, [email protected]
Share this article